Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Biol Pharm Bull ; 37(9): 1480-5, 2014.
Article in English | MEDLINE | ID: mdl-25177031

ABSTRACT

Atopic dermatitis (AD) is a chronically relapsing, pruritic, eczematous skin disorder accompanying allergic inflammation. AD is triggered by oxidative stress and immune imbalance. In the present study, we investigated the effect of drinking hydrogen water (HW) on 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis in NC/Nga mice and found that HW ameliorated DNCB-induced AD-like clinical symptoms. In line with this, the level of reactive oxygen species in the HW group was significantly inhibited compared with that in the purified water (PW) group. In parallel, HW enhanced glutathione peroxidase activity in DNCB-induced AD as compared with the PW group. Accordingly, the levels of thymus and activation-regulated chemokine and cytokines were significantly decreased in the HW group compared with the PW group. Notably, the levels of Th2 cytokine, interleukin-5 (IL-5), and proinflammatory cytokines such as tumor necrosis factor-α and IL-6 in HW-fed mice were significantly lower than in control and PW-fed mice. The total serum immunoglobulin E level was also markedly reduced in the HW group. The collective results indicate that HW suppresses DNCB-induced AD in NC/Nga mice via redox balance and immune modulation and could be a safe clinical fluid treatment for AD.


Subject(s)
Dermatitis, Atopic/drug therapy , Hydrogen/therapeutic use , Animals , Cytokines/blood , Dermatitis, Atopic/blood , Dermatitis, Atopic/chemically induced , Dermatitis, Atopic/urine , Dinitrochlorobenzene , Glutathione Peroxidase/blood , Hydrogen/pharmacology , Immunoglobulin E/blood , Leukocyte Count , Male , Malondialdehyde/urine , Mice , Reactive Oxygen Species/blood , Water
2.
Article in English | MEDLINE | ID: mdl-24348704

ABSTRACT

Hydrogen water (HW) produced by electrolysis of water has characteristics of extremely low oxidation-reduction potential (ORP) value and high dissolved hydrogen (DH). It has been proved to have various beneficial effects including antioxidant and anti-inflammatory effects; however, HW effect on atopic dermatitis (AD), an inflammatory skin disorder, is poorly documented. In the present study, we examined the immunological effect of drinking HW on Dermatophagoides farinae-induced AD-like skin in NC/Nga mice. Mice were administered with HW and purified water (PW) for 25 days. We evaluated the serum concentration of pro-inflammatory (TNF- α ), Th1 (IFN- γ , IL-2, and IL-12p70), Th2 (IL-4, IL-5, and IL-10), and cytokine expressed by both subsets (GM-CSF) to assess their possible relationship to the severity of AD. The serum levels of cytokines such as IL-10, TNF- α , IL-12p70, and GM-CSF of mice administered with HW was significantly reduced as compared to PW group. The results suggest that HW affects allergic contact dermatitis through modulation of Th1 and Th2 responses in NC/Nga mice. This is the first note on the drinking effect of HW on AD, clinically implying a promising potential remedy for treatment of AD.

3.
Article in English | MEDLINE | ID: mdl-21785648

ABSTRACT

Bambusae caulis in Liquamen (BCL), traditional herbal medicine used in East Asia, is known to have antioxidative and immune-regulating properties. We hypothesized that the potential antioxidant effects of BCL might suppress the production of thymus and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC) in human keratinocytes (HaCaT cell). The immune-regulating effect of BCL was demonstrated by antioxidant capacity using DPPH analysis and DCFH-DA analysis. We found that BCL had strong ROS scavenge effect in HaCaT cell. BCL also showed suppression of IFN-γ-induced expression of TARC and MDC, activation of NF-κB, and, moreover, significant block of IFN-γ-induced degradation and phosphorylation of IκB. However, it had no effects on phosphorylation of p38 MAPK. Collectively, these results suggest that BCL may have a therapeutic potential on skin disease such as atopic dermatitis by inhibiting Th2 chemokines which is due, at least in part, to its antioxidant capacities.

4.
Biol Pharm Bull ; 34(11): 1671-7, 2011.
Article in English | MEDLINE | ID: mdl-22040878

ABSTRACT

Electrolyzed reduced water (ERW), functional water, has various beneficial effects via antioxidant mechanism in vivo and in vitro. However there is no study about beneficial effects of ERW bathing. This study aimed to determine the effect of ERW bathing on the UVB-induced skin injury in hairless mice. For this purpose, mice were irradiated with UVB to cause skin injury, followed by individually taken a bath in ERW (ERW-bathing) and tap water (TW-bathing) for 21 d. We examined cytokines profile in acute period, and histological and ultrastructural observation of skin in chronic period. We found that UVB-mediated skin injury of ERW-bathing group was significantly low compared to TW control group in the early stage of experiment. Consistently, epidermal thickening as well as the number of dermal mast cell was significantly lowered in ERW-bathing group. Defection of corneocytes under the scanning electron microscope was less observed in ERW-bathing group than in TW-bathing group. Further, the level of interleukin (IL)-1ß, tumor necrosis factor (TNF)-α and IL-12p70 in ERW group decreased whereas those of IL-10 increased. Collectively, our data indicate that ERW-bathing significantly reduces UVB-induced skin damage through influencing pro-/anti-inflammatory cytokine balance in hairless mice. This suggests that ERW-bathing has a positive effect on acute UVB-mediated skin disorders. This is the first report on bathing effects of ERW in UVB-induced skin injury.


Subject(s)
Baths , Cytokines/metabolism , Dermatologic Agents/therapeutic use , Electrolysis , Skin Diseases/prevention & control , Skin/drug effects , Water/pharmacology , Animals , Dermatologic Agents/pharmacology , Functional Food , Hydrotherapy , Inflammation Mediators/metabolism , Interleukin-10/metabolism , Interleukin-12/metabolism , Interleukin-1beta/metabolism , Male , Mast Cells/metabolism , Mice , Mice, Hairless , Microscopy, Electron, Scanning , Skin/pathology , Skin/radiation effects , Skin Aging/drug effects , Skin Diseases/metabolism , Skin Diseases/pathology , Tumor Necrosis Factor-alpha/metabolism , Ultraviolet Rays/adverse effects , Water/chemistry
5.
Food Chem Toxicol ; 49(8): 1814-9, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21570445

ABSTRACT

Our hypothesis is that the intake of functional water, electrolyzed reduced water (ERW) can excrete melamine in body was evoked by melamine-tainted feed (MTF). To address this issue, we investigated the effect of ERW in MTF-mice model by way of body weight gain, incidence of urinary crystals and bladder stone, biochemical and haematological examination, histopathologic finding of kidney and urinary bladder, and the evaluation of bladder stone. We found that the rate of body weight gain was significantly more increased in MTF+ERW group than MTF+PW group. Accordingly, the number of immunocytes such as leukocyte, neutrophil and monocyte as well as the mean weight of spleen was significantly increased in MTF+ERW group. The incidence of urinary crystals was significantly higher in MTF+ERW group, whereas the incidence of urinary bladder stones was lower in MTF+ERW group (52.4%) than in MTF+PW group (38.1%). Also, urinary crystals were more precipitated in MTF+ERW group than MTF+PW group, and urinary bladder stone consists of 100% melamine. Collectively, our data clearly show that ERW intake is helpful to excrete of melamine in MTF mice model and this is the first report on the melamine excretion and clinically implying the safer fluid remedy for melamine-intoxicated hosts.


Subject(s)
Triazines/toxicity , Urinary Bladder Calculi/chemically induced , Water/chemistry , Animals , Body Weight/drug effects , Electrolysis , Female , Kidney/pathology , Mice , Mice, Inbred ICR , Organ Size , Triazines/administration & dosage , Urinary Bladder/pathology
6.
J Cell Physiol ; 226(1): 58-65, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20625996

ABSTRACT

The increased generation of reactive oxygen species (ROS) induces inflammation in different cell types. However, it is unclear whether ROS play an essential role in the production of thymus and activation-regulated chemokine (TARC/CCL17) and macrophage-derived chemokine (MDC/CCL22) in keratinocytes. Here, we investigated the function of ROS in the production of these two Th2 chemokines in interferon-gamma (IFN-γ)-treated HaCaT keratinocytes. We found that IFN-γ-induced production of both chemokines in parallel with the increased generation of intracellular ROS. A ROS scavenger, N-acetyl cysteine (NAC), significantly inhibited the IFN-γ-induced production of chemokines as well as the activation of I kappa-B (IκB)-nuclear factor-kappa B (NF-κB). Inhibitors of Janus family kinases (JAKs), p38 mitogen-activated kinase (MAPK), and NF-κB suppressed IFN-γ-induced production of TARC and MDC. NF-κB activation was inhibited by both inhibitors of JAKs and p38 MAPK. Importantly, IFN-γ-stimulated phosphorylation of p38 MAPK was significantly suppressed by JAKs inhibitors, but not significantly affected by NAC or L-buthionine sulfoximine (L-BSO). However, IFN-γ-stimulated activation of IκB and NF-κB was suppressed by NAC but enhanced by BSO. Furthermore, inhibition of p38 MAPK and JAKs did not affect ROS generation in IFN-γ-stimulated HaCaT cells. These results indicate that intracellular ROS and JAKs/p38 MAPK both contribute independently to IFN-γ-stimulated production of TARC and MDC in HaCaT keratinocytes, by increasing NF-κB activation.


Subject(s)
Chemokine CCL17/metabolism , Chemokine CCL22/metabolism , Gene Expression Regulation/drug effects , Interferon-gamma/pharmacology , Keratinocytes/metabolism , Reactive Oxygen Species/metabolism , Cell Line , Chemokine CCL17/genetics , Chemokine CCL22/genetics , Free Radical Scavengers , Humans , Keratinocytes/drug effects , Mitogen-Activated Protein Kinase Kinases/metabolism , NF-kappa B/genetics , NF-kappa B/metabolism
7.
Toxicol Lett ; 199(3): 277-87, 2010 Dec 15.
Article in English | MEDLINE | ID: mdl-20883752

ABSTRACT

Recent studies have suggested that oxidative stress may play a role in the cytotoxic activity of statins against cancer cells. The objective of this study was to elucidate the role of oxidative stress in the cytotoxicity of simvastatin in murine CT26 colon carcinoma cells and B16BL6 melanoma cells. We found that CT26 cells were more sensitive to simvastatin than B16BL16 cells. Interestingly, exposure to simvastatin causes significant apoptotic cell death and perturbations in parameters indicative of oxidative stress in CT26 cells. Moreover, the increase in oxidative stress parameters and cell death were suppressed by isoprenoids including mevalonolactone, farnesyl pyrophosphate ammonium salt, geranylgeranyl pyrophosphate ammonium salt, and coenzyme Q10, and by antioxidants including N-acetyl cysteine, reduced glutathione, superoxide dismutases (SOD), and catalase (CAT) alone or in combination, but were promoted by an inhibitor of glutathione synthesis, L-buthionine-sulfoximine. The signaling pathway induced by simvastatin breaks down the antioxidant defense system by suppressing the expression of reactive oxygen species scavengers, particularly Mn-SOD, CAT, GPx1, and SESN 3, thereby inducing oxidative stress and apoptotic cell death. Collectively, our results demonstrate that simvastatin induces colon cancer cell death at least in part by increasing intracellular oxidative stress and inducing apoptosis.


Subject(s)
Apoptosis/drug effects , Colonic Neoplasms/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Oxidative Stress , Simvastatin/pharmacology , Acetylcysteine/pharmacology , Animals , Buthionine Sulfoximine/pharmacology , Cell Line, Tumor , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Glutathione/pharmacology , Mice , Oligopeptides/pharmacology , Polyisoprenyl Phosphates/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , Reactive Oxygen Species/metabolism
8.
Biomed Res ; 30(5): 263-9, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19887722

ABSTRACT

Ethanol consumption disturbs the balance between the pro- and anti-oxidant systems of the organism, leading to oxidative stress. Electrolyzed-reduced water (ERW) is widely used by people in East Asia for drinking purposes because of its therapeutic properties including scavenging effect of reactive oxygen species. This study was performed to investigate the effect of ERW on acute ethanol-induced hangovers in Sprague-Dawley rats. Alcohol concentration in serum of ERW-treated rats showed significant difference at 1 h, 3 h and 5 h respectively as compared with the rats treated with distilled water. Both alcohol dehydrogenase type 1 and acetaldehyde dehydrogenase related with oxidation of alcohol were significantly increased in liver tissue while the level of aspartate aminotransferase and alanine aminotransferase in serum was markedly decreased 24 h after pre-oral administration of ERW. Moreover, oral administration of ERW significantly activated non-ezymatic (glutathione) and enzymatic (glutathione peroxidase, glutathione-S-transferase, Cu/Zn-superoxide dismutase and catalase) antioxidants in liver tissues compared with the control group. These results suggest that drinking ERW has an effect of alcohol detoxification by antioxidant mechanism and has potentiality for relief of ethanol-induced hangover symptoms.


Subject(s)
Electrolysis , Ethanol/toxicity , Water/chemistry , Alcohol Dehydrogenase/metabolism , Alcoholic Intoxication/metabolism , Aldehyde Oxidoreductases/metabolism , Animals , Antioxidants/metabolism , Catalase/metabolism , Ethanol/blood , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Liver/enzymology , Oxidation-Reduction , Oxidative Stress , Random Allocation , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Superoxide Dismutase/metabolism
9.
Br J Pharmacol ; 157(8): 1441-50, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19594754

ABSTRACT

BACKGROUND AND PURPOSE: The macrophage-derived chemokine (MDC/CCL22) is a prototypic Th2-type chemokine intimately involved in Th2-skewed allergic diseases, such as atopic dermatitis and asthma. The statins (3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors) have been demonstrated to relieve allergic inflammation. However, the immunological effects and mechanisms of statins against atopic dermatitis remain unknown, at least in vitro. This study aimed to define how different statins affect MDC expression in HaCaT cells, a human keratinocyte cell line. EXPERIMENTAL APPROACH: To measure the effects of statins on MDC expression in HaCaT cells, we used a cell viability assay, reverse transcription-polymerase chain reaction, enzyme-linked immunosorbent assay and Western blotting analyses. KEY RESULTS: Fluvastatin, but not atorvastatin or simvastatin, inhibited MDC expression induced by interferon (IFN)-gamma and NF-kappaB activation. A NF-kappaB inhibitor, but not a STAT1 inhibitor, suppressed MDC expression in HaCaT cells. Further, inhibition of p38 mitogen-activated protein kinases (MAPKs) significantly suppressed IFN-gamma-induced MDC expression and NF-kappaB activation. Interestingly, fluvastatin suppressed IFN-gamma-induced NF-kappaB activation in parallel with p38 MAPK phosphorylation. CONCLUSIONS AND IMPLICATIONS: These results indicate that fluvastatin inhibited expression of the CC chemokine MDC induced by IFN-gamma in HaCaT cells, by inhibiting NF-kappaB activation via the p38 MAPK pathway. This blockade of a Th2 chemokine by fluvastatin may suppress the infiltration of Th2 cells into skin lesions and lessen the skin inflammation seen in atopic dermatitis, suggesting a potential therapeutic use of fluvastatin for this condition.


Subject(s)
Chemokine CCL22/antagonists & inhibitors , Fatty Acids, Monounsaturated/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Indoles/pharmacology , Interferon-gamma/pharmacology , Keratinocytes/metabolism , Atorvastatin , Cell Line , Chemokine CCL22/biosynthesis , Fluvastatin , Heptanoic Acids/pharmacology , Humans , NF-kappa B/agonists , NF-kappa B/metabolism , Pyrroles/pharmacology , Signal Transduction , Simvastatin/pharmacology , Th2 Cells/metabolism , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/metabolism
10.
J Cell Physiol ; 220(3): 690-7, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19472212

ABSTRACT

Interferon (IFN)-gamma-induced protein 10 (IP-10/CXCL10), a CXC chemokine, has been documented in several inflammatory and autoimmune disorders including atopic dermatitis and bronchial asthma. Although CXCL10 could be induced by IFN-gamma depending on cell type, the mechanisms regulating CXCL10 production following treatment with combination of IFN-gamma and TNF-alpha have not been adequately elucidated in human monocytes. In this study, we showed that TNF-alpha had more potential than IFN-gamma to induce CXCL10 production in THP-1 monocytes. Furthermore, IFN-gamma synergistically enhanced the production of CXCL10 in parallel with the activation of NF-kappaB in TNF-alpha-stimulated THP-1 cells. Blockage of STAT1 or NF-kappaB suppressed CXCL10 production. JAKs inhibitors suppressed IFN-gamma plus TNF-alpha-induced production of CXCL10 in parallel with activation of STAT1 and NF-kappaB, while ERK inhibitor suppressed production of CXCL10 as well as activation of NF-kappaB, but not that of STAT1. IFN-gamma-induced phosphorylation of JAK1 and JAK2, whereas TNF-alpha induced phosphorylation of ERK1/2. Interestingly, IFN-gamma alone had no effect on phosphorylation and degradation of IkappaB-alpha, whereas it significantly promoted TNF-alpha-induced phosphorylation and degradation of IkappaB-alpha. These results suggest that TNF-alpha induces CXCL10 production by activating NF-kappaB through ERK and that IFN-gamma induces CXCL10 production by increasing the activation of STAT1 through JAKs pathways. Of note, TNF-alpha-induced NF-kappaB may be the primary pathway contributing to CXCL10 production in THP-1 cells. IFN-gamma potentiates TNF-alpha-induced CXCL10 production in THP-1 cells by increasing the activation of STAT1 and NF-kappaB through JAK1 and JAK2.


Subject(s)
Chemokine CXCL10/metabolism , Interferon-gamma/metabolism , Monocytes/immunology , Signal Transduction , Tumor Necrosis Factor-alpha/metabolism , Cell Line , Enzyme Activation , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , I-kappa B Proteins/metabolism , Janus Kinase 1/antagonists & inhibitors , Janus Kinase 1/metabolism , Janus Kinase 2/antagonists & inhibitors , Janus Kinase 2/metabolism , Mitogen-Activated Protein Kinase Kinases/metabolism , Monocytes/drug effects , Monocytes/enzymology , NF-KappaB Inhibitor alpha , NF-kappa B/metabolism , Phosphorylation , Protein Kinase Inhibitors/pharmacology , Receptors, Tumor Necrosis Factor, Type I/metabolism , Receptors, Tumor Necrosis Factor, Type II/metabolism , Recombinant Proteins/metabolism , STAT1 Transcription Factor/metabolism , Signal Transduction/drug effects , Up-Regulation
11.
J Ethnopharmacol ; 123(2): 195-200, 2009 Jun 22.
Article in English | MEDLINE | ID: mdl-19429362

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Bambusae caulis in Liquamen (BCL) is a nutritious liquid extracted from heat-treated fresh bamboo stems. It is an important traditional herbal medicine used to treat coughs and asthma in East Asia. In recent years, it has been studied for its anti-inflammatory, anti-allergenic, and immune-regulating properties. AIM OF THE STUDY: To examine whether BCL suppresses the development of 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD)-like skin lesions in hairless mice. MATERIALS AND METHODS: The effects of BCL were analyzed by measuring transepidermal water loss (TEWL), melanin content, and erythema in the skin, leukocyte numbers and IgE levels in the serum, and mRNA expression of relevant cytokines in the spleen. RESULTS: The transdermal administration of BCL to hairless mice inhibited the development of DNCB-induced AD-like skin lesions by suppressing TEWL, melanin production and erythema of skin, the number of leukocytes and the level of IgE in serum, and the mRNA expression of IL-4, IL-13, and TNF-alpha in the spleen. However, BCL administration increased the expression of IFN-gamma in the spleen. CONCLUSIONS: These findings indicate that BCL suppresses the development of DNCB-induced AD-like skin lesions in hairless mice, suggesting that BCL may be a potential therapeutic agent for AD in a clinical setting.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Bambusa/chemistry , Dermatitis, Atopic/drug therapy , Plant Extracts/pharmacology , Administration, Cutaneous , Animals , Anti-Inflammatory Agents/isolation & purification , Cytokines/drug effects , Cytokines/genetics , Dermatitis, Atopic/physiopathology , Dinitrochlorobenzene , Disease Models, Animal , Erythema/drug therapy , Erythema/etiology , Female , Gene Expression Regulation/drug effects , Immunoglobulin E/blood , Immunoglobulin E/drug effects , Medicine, East Asian Traditional , Melanins/metabolism , Mice , Mice, Hairless , Plant Stems , Spleen/drug effects , Spleen/metabolism
12.
Mol Immunol ; 46(10): 1925-34, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19371952

ABSTRACT

Patients with atopic dermatitis (AD) have significantly reduced plasma cAMP levels, and the cAMP level is correlated with the immunopathogenesis of AD. The production of thymus and activation-regulated chemokine (TARC/CCL17) and macrophage-derived chemokine (MDC/CCL22) in keratinocytes is significantly enhanced in patients with AD. In the present study, we investigated the in vitro effects of the adenylyl cyclase-cAMP system on IFN-gamma and TNF-alpha-stimulated production of TARC and MDC in human HaCaT keratinocytes. Both forskolin (a direct activator of adenylyl cyclase) and dibutyryl-cAMP (DBcAMP, a permeable analog of cAMP) suppressed production of TARC and MDC in parallel with the activation of NF-kappaB in IFN-gamma and TNF-alpha-stimulated HaCaT cells. Moreover, inhibition of NF-kappaB suppressed TARC and MDC production induced by IFN-gamma plus TNF-alpha. However, dideoxyforskolin, a forskolin derivative that does not activate cAMP, failed to suppress the secretion of these chemokines. An inhibitor of p38 MAPK suppressed the production of TARC and MDC in parallel to the activation of NF-kappaB in HaCaT cells. Of note, the IFN-gamma plus TNF-alpha-stimulated activation of p38 MAPK was suppressed following incubation with forskolin or DBcAMP alone. These results indicate that the adenylyl cyclase-cAMP system has an inhibitory role in IFN-gamma plus TNF-alpha-stimulated production of TARC and MDC in HaCaT keratinocytes by inhibiting NF-kappaB activation through p38 MAPK pathway, implying that the adenylyl cyclase-cAMP system could be a candidate therapeutic target of Th2-skewed skin inflammation such as AD.


Subject(s)
Adenylyl Cyclases/metabolism , Chemokine CCL17/biosynthesis , Chemokine CCL22/biosynthesis , Cyclic AMP/metabolism , Keratinocytes/enzymology , NF-kappa B/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , 8-Bromo Cyclic Adenosine Monophosphate/analogs & derivatives , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Adenine/analogs & derivatives , Adenine/pharmacology , Bucladesine/pharmacology , Colforsin/analogs & derivatives , Colforsin/pharmacology , Enzyme Activation/drug effects , Humans , Interferon-gamma/pharmacology , Keratinocytes/drug effects , Models, Immunological , STAT1 Transcription Factor/metabolism , Thionucleotides/pharmacology , Tumor Necrosis Factor-alpha/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...